Caffeine in neurons (Homo sapiens)
From WikiPathways
Description
Caffeine acts as a competitive antagonist at adenosine receptors -- particularly the A₁ and A₂A subtypes -- thereby promoting wakefulness and modifying the activity of key neurotransmitters, including dopamine, epinephrine, norepinephrine, and serotonin, within the central nervous system. Inspired by [Figure 1 in Kumar and Lipshultz, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6915633).
Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Kumar VHS, Lipshultz SE; ''Caffeine and Clinical Outcomes in Premature Neonates.''; Children (Basel), 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| ADORA2A | GeneProduct | ENSG00000128271 (Ensembl) ![]() | "A3" in source |
| ADRA1A | GeneProduct | ENSG00000120907 (Ensembl) ![]() | "A1" in source |
| ADRA1B | GeneProduct | ENSG00000170214 (Ensembl) ![]() | "A1" in source |
| ADRA1D | GeneProduct | ENSG00000171873 (Ensembl) ![]() | "A1" in source |
| Adenosine | Metabolite | CHEBI:16335 (ChEBI) ![]() | |
| Arousal | Q379784 (Wikidata) ![]() | ||
| Blood vessels | Pathway | WP5601 (WikiPathways) ![]() | |
| Caffeine | Metabolite | CHEBI:27732 (ChEBI) ![]() | |
| GABA | Metabolite | CHEBI:16865 (ChEBI) ![]() | |
| Myocytes | Pathway | WP5603 (WikiPathways) ![]() | |
| NT | Metabolite | CHEBI:25512 (ChEBI) ![]() | |
| Neurons | Pathway | WP5602 (WikiPathways) ![]() | |
| Neurotransmitter release | Q14863664 (Wikidata) ![]() | ||
| Signal transmission | Q14914309 (WikiPathways) ![]() | ||
| Sleep |
Annotated Interactions
No annotated interactions
Saving...

